|
|
|
Stem Cell Related Patent Number US5821096
| Title: | Peptidoglycan biosynthetic gene murE from Streptococcus pneumoniae | | Inventors: | Peery, Robert Brown; Brownsburg, IN, USA
Skatrud, Paul Luther; Indianapolis, IN, USA | | Summary: | Described herein is a Streptococcus pneumoniae MurE protein, methods and uses thereof. The invention relates to isolated nucleic acid compounds encoding the MurE stem peptide biosynthetic gene of Streptococcus pneuinoniae. Further disclosed are vectors and transformed heterologous host cells for expressing the MurE enzyme product, and a method for identifying compounds that inhibit stem peptide biosynthesis. This invention represents a variation of other applications filed by the same assignee. | | Abstract: | The invention provides isolated nucleic acid compounds encoding the murE stem peptide biosynthetic gene of Streptococcus pneuinoniae. Also provided are vectors and transformed heterologous host cells for expressing the murE enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US5821096 | | Application Number: | US1997000818857 | | Date Filed: | 17/03/1997 | | Date Published: | 13/10/1998 | | Assignee: | Eli Lilly and Company, Indianapolis, IN, USA |
|
|
